These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

82 related articles for article (PubMed ID: 8918274)

  • 1. Carrying a genetic passport for ovarian cancer.
    Modan B
    Lancet; 1996 Nov; 348(9038):1328. PubMed ID: 8918274
    [No Abstract]   [Full Text] [Related]  

  • 2. A breast/ovarian cancer patient with germline mutations in both BRCA1 and BRCA2.
    Ramus SJ; Friedman LS; Gayther SA; Ponder BA; Bobrow L; van der Looji M; Papp J; Olah E
    Nat Genet; 1997 Jan; 15(1):14-5. PubMed ID: 8988162
    [No Abstract]   [Full Text] [Related]  

  • 3. The Brca1 and Brca2 proteins and tumor pathogenesis.
    Ingvarsson S
    Anticancer Res; 1999; 19(4B):2853-61. PubMed ID: 10652564
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Genetic predisposition testing: taking the lead.
    Muto MG
    Gynecol Oncol; 1997 Nov; 67(2):121-2. PubMed ID: 9367692
    [No Abstract]   [Full Text] [Related]  

  • 5. Founder BRCA1 mutations and two novel germline BRCA2 mutations in breast and/or ovarian cancer families from North-Eastern Poland.
    van Der Looij M; Wysocka B; Brozek I; Jassem J; Limon J; Olah E
    Hum Mutat; 2000 May; 15(5):480-1. PubMed ID: 10790213
    [TBL] [Abstract][Full Text] [Related]  

  • 6. BRCA1 and BRCA2 mutations among 233 unselected Finnish ovarian carcinoma patients.
    Sarantaus L; Vahteristo P; Bloom E; Tamminen A; Unkila-Kallio L; Butzow R; Nevanlinna H
    Eur J Hum Genet; 2001 Jun; 9(6):424-30. PubMed ID: 11436123
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Mutational analysis of BRCA1 and BRCA2 genes in Chinese ovarian cancer identifies 6 novel germline mutations.
    Khoo US; Ngan HY; Cheung AN; Chan KY; Lu J; Chan VW; Lau S; Andrulis IL; Ozcelik H
    Hum Mutat; 2000 Jul; 16(1):88-9. PubMed ID: 10874312
    [TBL] [Abstract][Full Text] [Related]  

  • 8. BRCA1 and BRCA2 mutations in Turkish breast/ovarian families and young breast cancer patients.
    Yazici H; Bitisik O; Akisik E; Cabioglu N; Saip P; Muslumanoglu M; Glendon G; Bengisu E; Ozbilen S; Dincer M; Turkmen S; Andrulis IL; Dalay N; Ozcelik H
    Br J Cancer; 2000 Sep; 83(6):737-42. PubMed ID: 10952777
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Inherited predisposition to breast cancer.
    Ponder BA
    Biochem Soc Symp; 1998; 63():223-30. PubMed ID: 9513726
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Characterization of ten novel and 13 recurring BRCA1 and BRCA2 germline mutations in Italian breast and/or ovarian carcinoma patients. Mutations in brief no. 178. Online.
    De Benedetti VM; Radice P; Pasini B; Stagi L; Pensotti V; Mondini P; Manoukian S; Conti A; Spatti G; Rilke F; Pierotti MA
    Hum Mutat; 1998; 12(3):215. PubMed ID: 10660329
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Evidence of founder mutations in Finnish BRCA1 and BRCA2 families.
    Huusko P; Pääkkönen K; Launonen V; Pöyhönen M; Blanco G; Kauppila A; Puistola U; Kiviniemi H; Kujala M; Leisti J; Winqvist R
    Am J Hum Genet; 1998 Jun; 62(6):1544-8. PubMed ID: 9585608
    [No Abstract]   [Full Text] [Related]  

  • 12. Mutation analysis of the BRCA1 and BRCA2 genes results in the identification of novel and recurrent mutations in 6/16 flemish families with breast and/or ovarian cancer but not in 12 sporadic patients with early-onset disease. Mutations in brief no. 224. Online.
    Claes K; Machackova E; De Vos M; Mortier G; De Paepe A; Messiaen L
    Hum Mutat; 1999; 13(3):256. PubMed ID: 10090482
    [TBL] [Abstract][Full Text] [Related]  

  • 13. [BRCA1 and BRCA2--breast cancer susceptibility genes].
    Dagan E; Gershoni-Baruch R
    Harefuah; 1997 Nov; 133(10):455-7. PubMed ID: 9418320
    [No Abstract]   [Full Text] [Related]  

  • 14. High frequency of BRCA1 and BRCA2 germline mutations in Ashkenazi Jewish ovarian cancer patients, regardless of family history.
    Beller U; Halle D; Catane R; Kaufman B; Hornreich G; Levy-Lahad E
    Gynecol Oncol; 1997 Nov; 67(2):123-6. PubMed ID: 9367693
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Increased frequency of TP53 mutations in BRCA1 and BRCA2 ovarian tumours.
    Ramus SJ; Bobrow LG; Pharoah PD; Finnigan DS; Fishman A; Altaras M; Harrington PA; Gayther SA; Ponder BA; Friedman LS
    Genes Chromosomes Cancer; 1999 Jun; 25(2):91-6. PubMed ID: 10337991
    [TBL] [Abstract][Full Text] [Related]  

  • 16. No stranger to controversy.
    Nat Genet; 1997 Nov; 17(3):247-8. PubMed ID: 9354774
    [No Abstract]   [Full Text] [Related]  

  • 17. A high occurrence of BRCA1 and BRCA2 mutations among Czech hereditary breast and breast-ovarian cancer families.
    Machácková E; Foretová L; Navrátilová M; Valík D; Claes K; Messiaen L
    Cas Lek Cesk; 2000 Oct; 139(20):635-7. PubMed ID: 11192759
    [TBL] [Abstract][Full Text] [Related]  

  • 18. BRCA1 and BRCA2 mutation carriers as potential candidates for chemoprevention trials.
    Levy-Lahad E; Krieger M; Gottfeld O; Renbaum P; Klein G; Eisenberg S; Lahad A; Kaufman B; Catane R
    J Cell Biochem Suppl; 2000; 34():13-8. PubMed ID: 10762009
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Association of the I1307K APC mutation with hereditary and sporadic breast/ovarian cancer: more questions than answers.
    Gershoni-Baruch R; Patael Y; Dagan ; Figer A; Kasinetz L; Kadouri E; Bruchim Bar Sade R; Friedman E
    Br J Cancer; 2000 Jul; 83(2):153-5. PubMed ID: 10901363
    [TBL] [Abstract][Full Text] [Related]  

  • 20. New BRCA2 mutation in an Ashkenazi Jewish family with breast and ovarian cancer.
    Robson ME; Offit K
    Lancet; 1997 Jul; 350(9071):117-8. PubMed ID: 9228974
    [No Abstract]   [Full Text] [Related]  

    [Next]    [New Search]
    of 5.